Skip to main content
SpringerLink
Log in

Inflammatory muscle disease assessment

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

In recent years, idiopathic inflammatory muscle disease assessment has advanced significantly with the development of an international consensus on outcome measurement indices. The International Myositis Assessment and Clinical Studies Group continues to evaluate the validity and reliability of various disease activity and disease damage tools, which will facilitate adequately controlled randomized trials of recently developed therapeutic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Levine TD: Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 2005, 52: 601–607.

    Article  PubMed  CAS  Google Scholar 

  2. Kendall FP, McCreary EK, Povance PG: Muscles: Testing and Function, 4th edn. Baltimore; Williams and Wilkins: 1993.

  3. Hinder KA, Hinderer SR: Muscle strength development and assessment in children and adolescents. In Muscle Strength. Edited by Harms-Ringdahl K. Edinburgh: Churchill Livingstone; 1993: 93–140.

    Google Scholar 

  4. Escolar DM, Henricson EK, Mayhew J, et al.: Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 2001, 24: 787–793.

    Article  PubMed  CAS  Google Scholar 

  5. Kroll M, Otis J, Kagen L: Serum enzyme, myoglobin and muscle strength relation in polymyositis and dermatomyositis. J Rheumatol 1986, 13: 349–355.

    PubMed  CAS  Google Scholar 

  6. Bohan A, Peter JB, Bowman RL, Pearson CM: Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977, 56: 255–286.

    CAS  Google Scholar 

  7. Sanmarti R, Collado A, Gratacos J, et al.: Reduced activity of serum creatine kinase in rheumatoid arthritis: a phenomenon linked to the inflammatory response. Br J Rheumatol 1994, 33: 231–234.

    Article  PubMed  CAS  Google Scholar 

  8. Erlacher P, Lercher A, Falkensammer J, et al.: Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clin Chim Acta 2001, 306: 27–33.

    Article  PubMed  CAS  Google Scholar 

  9. Bohlmeyer TJ, Wu AH, Perryman MB: Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis. Rheum Dis Clin N Am 1994, 20: 845–856.

    CAS  Google Scholar 

  10. Rider LG, Miller FW: Idiopathic inflammatory muscle disease: clinical aspects. Baillieres Best Pract Res Clin Rheumatol 2000, 14: 37–54.

    Article  PubMed  CAS  Google Scholar 

  11. Stone KB, Oddis CV, Fertig N, et al.: Anti-Jo1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum 2007, 56: 3125–3131.

    Article  PubMed  CAS  Google Scholar 

  12. Ng K, Smith C, Isenberg D: Muscular dystrophy mimicking refractory idiopathic inflammatory myositis: a trio of cases. Rheumatology (Oxford) 2007, 46: 1618–1619.

    Article  CAS  Google Scholar 

  13. Sultan SM: Clinical assessment in adult onset idiopathic inflammatory myopathy. Curr Opin Rheumatol 2004, 16: 668–672.

    Article  PubMed  CAS  Google Scholar 

  14. Park JH, Olsen NJ, King L, et al.: MRI and P-31 magnetic resonance spectroscopy detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 1995, 38: 68–77.

    Article  PubMed  Google Scholar 

  15. Pachman LM, Crawford S, Morrelo F, et al.: MRI directed muscle biopsy for assessment of juvenile dermatomyositis response to therapy: comparison on initial and follow up biopsies using histological rating scale evaluating disease severity/chronicity. Arthritis Rheum 1996, 38: 360.

    Google Scholar 

  16. Dorph C, Nennesmo I, Lundberg I: Percutaneous conchotome muscle biopsy: a useful diagnostic and assessment tool. J Rheumatol 2001, 60: 423–426.

    Google Scholar 

  17. Lampa J, Nennesmo I, Einarsdottir H, et al.: MRI-guided muscle biopsy confirmed polymyositis diagnosis in a patient with interstitial lung disease. Ann Rheum Dis 2001, 60: 423–426.

    Article  PubMed  CAS  Google Scholar 

  18. Christen-Zaech S, Seshadri R, Sundberg J, et al.: Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum 2008, 58: 571–576.

    Article  PubMed  Google Scholar 

  19. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV: Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990, 141: 727–733.

    PubMed  CAS  Google Scholar 

  20. Miller FW, Rider LG, Chung YL, et al.: Proposed preliminary core sets measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2001, 40: 1262–1273.

    Article  CAS  Google Scholar 

  21. Isenberg DA, Allen E, Farewell V, et al.: International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 2004, 43: 49–54.

    CAS  Google Scholar 

  22. Hay EM, Bacon PA, Gordon C, et al.: The BILAG index: a reliable and valid instrument for measuring clinical activity in systemic lupus erythematosus. Q J Med 1993, 86: 447–458.

    PubMed  CAS  Google Scholar 

  23. Whiting-O’Keefe QE, Stone J, Hellman DB: Validity of a vasculitis index for systemic necrotizing vasculitis. Arthritis Rheum 1999, 42: 2365–2371.

    Article  PubMed  CAS  Google Scholar 

  24. Gladman D, Ginzler E, Goldsmith C, et al.: The development and initial validation of the Systemic Lupus International Collaborating Clinics/America College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996, 39: 363–369.

    Article  PubMed  CAS  Google Scholar 

  25. Sultan S, Ioannou Y, Moss K, Isenberg DA: Outcome in patients with inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 2002, 41: 22–26.

    Article  CAS  Google Scholar 

  26. Sultan S, Allen E, Oddis C, et al.: Reliability and validity of the myositis disease activity assessment tool. Arthritis Rheum 2008 (in press).

Download references

Author information

Authors and Affiliations

  1. Centre for Rheumatology Room 331, 3rd Floor, Windeyer Building, University College London, 46 Cleveland Street, London, W1T 4JF, UK

    David A. Isenberg

Authors
  1. Tim Y. -T. Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristine P. Ng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David A. Isenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David A. Isenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lu, T.Y.T., Ng, K.P. & Isenberg, D.A. Inflammatory muscle disease assessment. Curr Rheumatol Rep 10, 328–332 (2008). https://doi.org/10.1007/s11926-008-0052-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-008-0052-3

Keywords

Search

Navigation